Literature DB >> 2643654

The Gorlin formula validated against directly observed orifice area in porcine mitral bioprostheses.

J B Chambers1, T Cochrane, M M Black, G Jackson.   

Abstract

To assess the effect of fluid flow on orifice area and to test the Gorlin formula, six Carpentier-Edwards mitral valve prostheses were studied in a positive displacement pulse duplicator at 20 different rate-stroke volume combinations. Peak transvalvular velocity (V max) was measured by continuous wave Doppler ultrasound, and orifice area was determined from hard copy of video images. Orifice area was directly related to mean flow (Q), although cusp opening behavior was asymmetric and complex and varied among the individual valves. There was a strong correlation between measured orifice area (OA) and the modified Gorlin relation, Q/V max (r = 0.88; p less than 0.00001) given by the regression formula OA = 0.18 x Q/V max - 0.15. There was also a good correlation between measured orifice area and the conventional Gorlin relation, Q/root mean pressure drop. The derived empiric Gorlin constant did not vary significantly with flow.

Entities:  

Mesh:

Year:  1989        PMID: 2643654     DOI: 10.1016/0735-1097(89)90510-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  3 in total

1.  Continuity equation and Gorlin formula compared with directly observed orifice area in native and prosthetic aortic valves.

Authors:  J B Chambers; D C Sprigings; T Cochrane; J Allen; R Morris; M M Black; G Jackson
Journal:  Br Heart J       Date:  1992-02

2.  Limitations of Doppler ultrasound in the assessment of the function of prosthetic mitral valves.

Authors:  J Chambers; G Jackson; D Jewitt
Journal:  Br Heart J       Date:  1990-03

3.  Doppler sonographic evaluation of mechanical and bioprosthetic mitral valve prostheses during exercise with a rate corrected pressure half time.

Authors:  P Weiss; A Hoffmann; D Burckhardt
Journal:  Br Heart J       Date:  1992-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.